The official journal of the Brazilian Retina and Vitreous Society
Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
Intravitreal faricimab, a bispecific antibody targeting both angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A), was recently introduced for the treatment of neovascular age-related macul...